Recursion Pharmaceuticals (RXRX) Capital Expenditures Growth (1y) (2021 - 2025)
Recursion Pharmaceuticals (RXRX) Capital Expenditures Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 227.76% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 396.15% |
| Sep 30, 2025 | -105.13% |
| Jun 30, 2025 | -174.70% |
| Mar 31, 2025 | -82.77% |
| Dec 31, 2024 | 117.43% |
| Sep 30, 2024 | -53.84% |
| Jun 30, 2024 | 596.64% |
| Mar 31, 2024 | 2,626.64% |
| Dec 31, 2023 | -121.93% |
| Sep 30, 2023 | 155.75% |
| Jun 30, 2023 | -101.44% |
| Mar 31, 2023 | -94.38% |
| Dec 31, 2022 | 660.89% |
| Sep 30, 2022 | -151.27% |
| Jun 30, 2022 | 188.32% |
| Mar 31, 2022 | -77.64% |
| Dec 31, 2021 | 700.00% |
| Sep 30, 2021 | 1,520.77% |
| Jun 30, 2021 | -2,671.62% |
| Mar 31, 2021 | 2,738.60% |